文献速递消化系统肿瘤

位于8q24.21「基因沙漠」的长链非编码RNA CCAT1和CCAT2是结直肠癌的重要预后生物标志物

CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.
PubMed 文献 · Ann Oncol · 2017-01-01

研究评估了8q24.21位点12种长链非编码RNA在280例结直肠癌及20例癌旁正常黏膜中的表达。CCAT1和CCAT2高表达与较差的无复发病生存和总生存相关,并在独立队列中验证。CCAT1、CCAT2与癌胚抗原联合表达可有效预测II期和III期结直肠癌的无复发病生存。

要点

  • CCAT1、CCAT1-L、CCAT2、PVT1和CASC19在癌组织中表达升高。
  • CCAT1和CCAT2高表达与较差的无复发病生存和总生存显著相关。
  • CCAT1、CCAT2与癌胚抗原联合表达可预测II期和III期结直肠癌无复发病生存。

核心结论

  • 8q24.21位点的多种长链非编码RNA在结直肠癌中高表达,CCAT1和CCAT2高表达与较差的无复发病生存和总生存显著相关,可作为结直肠癌的重要预后生物标志物。

研究设计与样本

  • 研究纳入300份组织标本,包括280例结直肠癌组织和20例癌旁正常黏膜,用qRT-PCR检测12种长链非编码RNA的表达。
  • 分析长链非编码RNA表达与临床病理特征、无复发病生存和总生存的关联,并在两个独立队列中验证。

主要发现

  • CCAT1、CCAT1-L、CCAT2、PVT1和CASC19在癌组织中表达升高,P值分别为0.039、<0.001、0.018、<0.001、0.002。
  • CCAT1和CCAT2高表达与较差的无复发病生存显著相关,P值分别为0.049和0.022。
  • CCAT1和CCAT2高表达与较差的总生存显著相关,P值分别为0.028和0.015。
  • 在独立验证队列中,CCAT1和CCAT2联合表达与较差的无复发病生存显著相关,HR为2.60(95%CI 1.04-6.06,P=0.042)。
  • 在独立验证队列中,CCAT1和CCAT2联合表达与较差的总生存显著相关,HR为8.38(95%CI 2.68-37.0,P<0.001)。

关键数值与推荐

  • CCAT1、CCAT1-L、CCAT2、PVT1和CASC19在癌组织中的表达升高,P值分别为0.039、<0.001、0.018、<0.001、0.002。
  • CCAT1和CCAT2高表达与较差的无复发病生存相关,P值分别为0.049和0.022;与较差的总生存相关,P值分别为0.028和0.015。
  • 独立验证队列中,CCAT1和CCAT2联合表达与较差的无复发病生存相关,HR为2.60(95%CI 1.04-6.06,P=0.042);与较差的总生存相关,HR为8.38(95%CI 2.68-37.0,P<0.001)。
  • CCAT1、CCAT2和癌胚抗原联合表达预测无复发病生存,II期患者P=0.034,III期患者P=0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 8q24.21 is a frequently amplified genomic region in colorectal cancer (CRC). This region is often referred to as a 'gene desert' due to lack of any important protein-coding genes, highlighting the potential role of noncoding RNAs, including long noncoding RNAs (lncRNAs) located around the proto-oncogene MYC. In this study, we have firstly evaluated the clinical significance of altered expression of lncRNAs mapped to this genomic locus in CRC. PATIENTS AND METHODS: A total of 300 tissues, including 280 CRC and 20 adjacent normal mucosa specimens were evaluated for the expression of 12 lncRNAs using qRT-PCR assays. We analyzed the associations between lncRNA expression and various clinicopathological features, as well as with recurrence free survival (RFS) and overall survival (OS) in two independent cohorts. RESULTS: The expression of CCAT1, CCAT1-L, CCAT2, PVT1, and CASC19 were elevated in cancer tissues (P = 0.039, <0.001, 0.018, <0.001, 0.002, respectively). Among these, high expression of CCAT1 and CCAT2 was significantly associated with poor RFS (P = 0.049 and 0.022, respectively) and OS (P = 0.028 and 0.015, respectively). These results were validated in an independent patient cohort, in which combined expression of CCAT1 and CCAT2 expression was significantly associated with a poor RFS (HR:2.60, 95% confidence interval [CI]: 1.04-6.06, P = 0.042) and a poor OS (HR:8.38, 95%CI: 2.68-37.0, P < 0.001). We established a RFS prediction model which revealed that combined expression of CCAT1, CCAT2, and carcinoembryonic antigen was a significant determinant for efficiently predicting RFS in stage II (P = 0.034) and stage III (P = 0.001) CRC patients. CONCLUSIONS: Several lncRNAs located in 8q24.21 locus are highly over-expressed in CRC. High expression of CCAT1 and CCAT2 significantly associates with poor RFS and OS. The expression of these two lncRNAs independently, or in combination, serves as important prognostic biomarkers in CRC.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Ozawa T, Matsuyama T, Toiyama Y, et al. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer. Ann Oncol. 2017. PMID: 28838211. doi:10.1093/annonc/mdx248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。